Fluconazole vs Nivolumab

Fluconazole vs Nivolumab: Overview

This comparison examines the pharmacological differences between Fluconazole and Nivolumab.

Mechanism of Action

Fluconazole: Inhibits fungal CYP51 (lanosterol 14-alpha-demethylase).

Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

Pharmacokinetics

Half-life: Fluconazole — 30 hours; Nivolumab — 27 days.

Chemical Properties

Molecular Formula: Fluconazole — C13H12F2N6O.

Molecular Weight: Fluconazole — 306.2710 g/mol.

Type: Fluconazole — Small molecule; Nivolumab — Antibody.